Recommendations for use of Hypofractionated radiotherapy for early (operable) breast cancer

September 2015 | Incorporates published evidence to September 2014

A CLINICAL PRACTICE GUIDELINE DEVELOPED BY CANCER AUSTRALIA

This guideline was first published in November 2011 and has been updated to incorporate new evidence. 

 

© Cancer Australia 2015

Purpose

This guideline includes statements, recommendations and practice points based on available, high-level evidence about the use of hypofractionated radiotherapy for the treatment of women with early (operable) breast cancer. The guideline aims to provide all health professionals within a multi-disciplinary team with information to assist in making management recommendations for improved patient outcomes.

Endorsed by:

Breast Surgeons of Australia & New Zealand
Breast Cancer Network Australia
The Faculty of Radiation Oncology, RANZCR